Related Experiment Videos
Systemic amyloidosis and ovarian carcinoma
C Fernandez-Miranda1, S Mateo, C Gonzalez-Gomez
1Department of Medicine and Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Postgraduate Medical Journal
|July 1, 1994
Summary
This report details a rare case of ovarian carcinoma and secondary amyloidosis in a 64-year-old woman presenting with nephrotic syndrome. The study highlights a previously undescribed association between these two conditions.
Area of Science:
- Oncology
- Nephrology
- Pathology
Background:
- Systemic amyloidosis, particularly secondary amyloidosis (AA amyloidosis), is often associated with chronic inflammatory or infectious diseases.
- Ovarian carcinoma is a significant gynecological malignancy with diverse presentations.
- Nephrotic syndrome can be a manifestation of systemic diseases affecting the kidneys.
Observation:
- A 64-year-old woman presented with nephrotic syndrome.
- Immunohistochemical analysis of renal and rectal biopsies confirmed AA amyloidosis.
- Gynecological sonogram revealed a pelvic mass, later identified as ovarian carcinoma during laparotomy.
Findings:
- The patient was diagnosed with poorly differentiated ovarian carcinoma.
- The presence of AA amyloidosis antigens indicated secondary amyloidosis.
- The absence of typical triggers for secondary amyloidosis pointed towards an underlying neoplasm.
Implications:
- This case represents a previously undescribed association between ovarian carcinoma and systemic AA amyloidosis.
- The findings suggest that ovarian carcinoma should be considered in the differential diagnosis of secondary amyloidosis, especially in the absence of overt chronic inflammatory conditions.
- Further research is warranted to understand the potential pathogenetic mechanisms linking ovarian neoplasms and systemic amyloid deposition.